DUBLIN--(BUSINESS WIRE)--The "Global Enteral Feeding Devices Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global enteral feeding devices market is estimated to register a
CAGR of 5.29% over the forecast period of 2017-2023.
Increasing use of these devices to supply nutrients to critically and
terminally ill patients and bed ridden patients is driving growth.
Rising use of the enteral feeding tubes in homecare settings will also
drive the market. The high uptake of these devices for treating
undernourished or malnourished patients with impaired immunity, wound
healing, and muscle strength in hospitals contribute to its high share.
Rising incidences of the gastrointestinal disorders, neurological
disorders and chronic diseases such as cancer will also augment the
market during the forecast period. As per the data by WHO, an estimated
of 9.6 million deaths in 2018 were caused by cancer, making it the
second largest cause of death worldwide.
Rising adoption of the enteral feeding tube as they cause less side
effects and have less chances of infection when compared to the
parenteral devices is also driving the market growth.
Technological advancements in the development of the enteral feeding
products including texture modifications, introduction of portable and
affordable devices will also boost the market.
Also, the rising number of geriatric population who are at the risk of
chronic disease have also bolstered the market during the given forecast
period.
However, stringent regulations by various regulatory bodies across the
globe and number of cases of accidental dislodgement and deaths might
restrain the market.
Geographically, North America holds the significant share owing to the
high awareness level regarding the enteral feeding devices. Effective
and favorable reimbursement policies pertaining to the enteral feeding
devices have also augmented the growth of the market in the region.
Asia Pacific will also show a robust growth during the given period
owing to the improving healthcare infrastructure and high patient base
due to high prevalence of the chronic disease and malnutrition.
Companies Profiled
- Boston Scientific Corporation
- GBUK Enteral Ltd.
- Nestle Health Science
- Q Holding Company
- Cardinal Health
- Vygon (UK) Ltd.
- Avanos
- Rockfield Medical Devices
- Applied Medical Technology Inc.
- Fresenius SE & Co. KGaA
For more information about this report visit https://www.researchandmarkets.com/research/tmjhgm/global_enteral?w=4
